^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    simmitecan

    Associations
    News

    Trials

    Company:
    HaiHe Biopharma, Shanghai Inst. of Materia Medica
    Drug class:
    Topoisomerase I inhibitor, HIF-1α inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma (NCT03992911)
    Phase 2/3
    Peking University
    Recruiting
    Last update posted :
    06/20/2019
    Initiation :
    06/19/2019
    Primary completion :
    06/20/2022
    Completion :
    06/20/2023
    PD-L1
    |
    PD-L1 expression
    |
    cisplatin • carboplatin • 5-fluorouracil • Loqtorzi (toripalimab-tpzi) • etoposide IV • simmitecan